期刊
CANCER TREATMENT REVIEWS
卷 27, 期 1, 页码 35-50出版社
ELSEVIER SCI LTD
DOI: 10.1053/ctrv.2000.0202
关键词
mitomycin C; cancers of the bladder breast; cervix; stomach; head and neck; lung; pancreas
类别
Mitomycin C was reviewed in this journal 25 years ago and an update of its clinical usefulness is appropriate. The current review is based on representative publications covering clinical trials performed throughout the world. Single agent activity in each of-the major neoplastic diseases has been reassessed when possible and the most important combinations evaluated. it is concluded that mitomycin C has a definite place in the treatment of localized bladder cancer; is active, but needs to be redefined, in the context of newer regimens for breast, head and neck, and non-small cell lung cancers, is active in. but is being displaced by, other drugs in cervical, gastric and pancreatic cancers, and is probably no longer of therapeutic value in colon cancer, it is also recognized that as many newer treatments have clinical success, the therapeutic role of mitomycin C will require continuing re-investigation. (C) 2001 Harcourt Publishers Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据